|
VIR Vir Biotechnology Inc 1706431 |
| Balance Sheet |
|
Current Assets
|
$522,985,000.00 |
|
Assets
|
$1,025,585,000.00 |
|
Current Liabilities
|
$73,558,000.00 |
|
Liabilities
|
$212,820,000.00 |
|
Equity
|
$812,765,000.00 |
|
Shares Out
|
161234058.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-132,386,000.00 |
|
Investing Cash Flow
|
$11,835,000.00 |
| Market Analysis |
Market Cap
|
$1,434,983,116.20 |
|
Price
|
$8.62 |
|
BVPS
|
5.04 |
|
PB
|
1.77 |
|
EPS
|
-0.85 |
|
PS
|
23.61 |
|
FCF
|
$-132,776,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:23 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:19 |
|
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-23 |
-0.31 |
|
| Apr |
May |
Jun |
|
|
|
|
2026-05-06 |
-0.85 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-06 |
-0.80 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-05 |
-1.17 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view VIR documents filed with the SEC.
VIR Filings
Clear
